Microsize has unveiled a strategic investment and partnership with Helsinki-based The Solubility Company. Microsize’s investment accelerates plans for The Solubility Company to open a U.S.-based solubility lab which will be located in Microsize’s facility in Quakertown, PA. North American-based pharmaceutical companies will have direct access to the AI-enabled Single Particle Analysis (SPA) technology to accurately measure solubility and dissolution rate with sample quantities as low as 1-2 milligrams.

The proprietary SPA technology allows for fast, reliable, and continuous measurements of the dissolution process directly from powder samples using machine vision and advanced AI providing accurate solubility measurements much earlier in the developmental process than what is currently possible. The technology will benefit Microsize customers who today utilize Microsize services to enhance solubility and bioavailability of drug candidates using particle size engineering including micronization and nanomilling.

“We couldn’t be more excited to support The Solubility Company in the expansion of this powerful technology to customers stateside,” said TJ Higley, CEO of Microsize. “While operating as a discreet and fully autonomous entity within our facilities, the synergistic value of The Solubility Company’s SPA technology to Microsize clients is meaningful. This partnership should further streamline, speed to market for our clients by combining early answers in solubility alongside our full suite of solid-state characterization capabilities under one roof. Adding this type characterization in parallel with our particle engineering technologies, we can unlock immense value in developing the best drug product intermediate for our clients.

Sami Svanbäck, CEO of The Solubility Company, said, “The funding will fuel our strategic expansion into the U.S., our main market. The partnership with Microsize presents an exciting opportunity to transform the drug development process for pharma clients.”

Microsize will immediately begin outfitting a discreet SPA lab and IT network along with customer visitation areas to allow The Solubility Company to begin testing samples in the U.S. by Q4 of this year.